Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma

Gestational choriocarcinoma metastasizes rapidly, in which process the vasoactive prostanoids may be significant. We therefore compared the urinary excretion of prostacyclin and thromboxane A2 (TxA2) metabolites in 19 women with gestational choriocarcinoma and 20 healthy age-matched women by assessi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 1991-08, Vol.51 (16), p.4146-4148
Hauptverfasser:	AITOKALLIO-TALLBERG, A. M, JUNG, J. K, KIM, S. J, VIINIKKA, L. U, YLIKORKALA, R. O
Format:	Artikel
Sprache:	eng
Schlagworte:	6-Ketoprostaglandin F1 alpha - analogs & derivatives 6-Ketoprostaglandin F1 alpha - urine Adult Biological and medical sciences Biomarkers, Tumor - urine Choriocarcinoma - urine Diseases of mother, fetus and pregnancy Epoprostenol - metabolism Female Gynecology. Andrology. Obstetrics Humans Medical sciences Pregnancy Pregnancy. Fetus. Placenta Reference Values Thromboxane A2 - metabolism Thromboxane A2 - urine Thromboxane B2 - analogs & derivatives Thromboxane B2 - urine Uterine Neoplasms - urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!